MINOXIDIL TOPICAL

Manufacturer
Wenchang Panzhijie Trading Co., Ltd.
Effective date
2024-08-23
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:18:04

Label at a glance#

ProductMINOXIDIL TOPICAL
Active ingredientMINOXIDIL
Label structure10 sections

Dosage and administration

Apply 1ml(5 Sprays) twice a day.Once in the morning and another time in the evening before bed. Spray directly on top of the scalp in the area to be treated. Discontinuing use may result in hair loss.

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Minoxidil 5%

Purpose

OTC - PURPOSE SECTION

Hair Regrowth Treatment

Use

INDICATIONS & USAGE SECTION

to regrow hair on the top of the scalp

Warnings

WARNINGS SECTION

• For external use only

• Keep away from fire and flame

• Avoid contact with eyes

Do not use

OTC - DO NOT USE SECTION

• You have no family history of hair loss. Hair loss is sudden and/or patchy.

• You do not know the reason for your hair loss.

• You are under 18 years of age.

• Do not use it onbabies and children.Scalp is red, inflamed, infected, irritated or painful.

• You use other medicines on the scalp.

STOP USE AND SEE A DOCTOR

OTC - STOP USE SECTION

• If scalp irritation or redness occurs.

• If you get unwanted facial hair growth.

• If you do not see hair regrowth in 4 months.

• If sudden, unexplained weight gain occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

Apply 1ml(5 Sprays) twice a day.Once in the morning and another time in the evening before bed.

Spray directly on top of the scalp in the area to be treated.

Discontinuing use may result in hair loss.

Inactive ingredients

INACTIVE INGREDIENT SECTION

WATER, PROPYLENE GLYCOL, GLYCERIN, ZINGIBER OFFICINALE(GINGER)ROOT EXTRACT, PEG-40 HYDROGENATED CASTOR OIL, PANAX GINSENG EXTRACT, BIOTIN, XANTHAN GUM, RICINUS COMMUNIS(CASTOR)OIL, ROSMARINUS OFFICINALIS(ROSEMARY)LEAF OIL.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

undefinedundefined

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1537948minoxidil 5 % Topical SprayPSN1
1537948minoxidil 50 MG/ML Topical SpraySCD1
1537948minoxidil 5 % Topical SpraySY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MINOXIDIL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83717-004-01MINOXIDIL TOPICAL60 mL in 1 BOTTLELIQUID601

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83717-004MINOXIDIL TOPICAL LIQUID [WENCHANG PANZHIJIE TRADING CO., LTD.]11 package rows20240830_20687945-c5ce-ff4f-e063-6394a90a0fd8.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83717-00483717-004-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
20687ad9-0e39-37f8-e063-6294a90a9a6220687945-c5ce-ff4f-e063-6394a90a0fd82024-08-23WarningsExact identifier
spl id: 20687ad9-0e39-37f8-e063-6294a90a9a62
spl set id: 20687945-c5ce-ff4f-e063-6394a90a0fd8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.